Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (lyve-1)

Purpose: - - Due to the lack of specific markers the analysis of lymphatic vessel density (LVD) has been almost impossible in the past. We report the novel specific marker for lymphatic endothelium, lymphatic vessel endothelial hyaluronan receptor (LYVE-1), in prostatic, benign prostatic hyperplasi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Trojan, Lutz (VerfasserIn) , Michel, Maurice Stephan (VerfasserIn) , Rensch, Florian (VerfasserIn) , Jackson, David G. (VerfasserIn) , Alken, Peter (VerfasserIn) , Grobholz, Rainer (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 Jul 2004
In: The journal of urology
Year: 2004, Jahrgang: 172, Heft: 1, Pages: 103-107
ISSN:1527-3792
DOI:10.1097/01.ju.0000128860.00639.9c
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/01.ju.0000128860.00639.9c
Verlag, lizenzpflichtig, Volltext: https://www.auajournals.org/doi/10.1097/01.ju.0000128860.00639.9c
Volltext
Verfasserangaben:Lutz Trojan, Maurice Stephan Michel, Florian Rensch, David G. Jackson, Peter Alken, Rainer Grobholz

MARC

LEADER 00000caa a2200000 c 4500
001 1794923179
003 DE-627
005 20220820142658.0
007 cr uuu---uuuuu
008 220307s2004 xx |||||o 00| ||eng c
024 7 |a 10.1097/01.ju.0000128860.00639.9c  |2 doi 
035 |a (DE-627)1794923179 
035 |a (DE-599)KXP1794923179 
035 |a (OCoLC)1341445742 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Trojan, Lutz  |d 1973-  |e VerfasserIn  |0 (DE-588)124059856  |0 (DE-627)706523571  |0 (DE-576)294001492  |4 aut 
245 1 0 |a Lymph and blood vessel architecture in benign and malignant prostatic tissue  |b lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (lyve-1)  |c Lutz Trojan, Maurice Stephan Michel, Florian Rensch, David G. Jackson, Peter Alken, Rainer Grobholz 
264 1 |c 1 Jul 2004 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.03.2022 
520 |a Purpose: - - Due to the lack of specific markers the analysis of lymphatic vessel density (LVD) has been almost impossible in the past. We report the novel specific marker for lymphatic endothelium, lymphatic vessel endothelial hyaluronan receptor (LYVE-1), in prostatic, benign prostatic hyperplasia (BPH) and prostate cancer (PCa) tissue. Normal blood vessels were additionally quantified in BPH and PCa. - - Materials and Methods: - - LYVE-1+ lymphatics (LVD) and CD34+ blood vessels were assessed in 20 paraffin sections of BPH and 50 of PCa tissue by immunohistochemistry in a standardized experimental setting. The regions of PCa, periphery of the tumor and nontumorous regions of the PCa specimens, and BPH tissue were evaluated. Double staining was done (LYVE-1/CD34). Acquired data were interrelated and compared to the pathological parameters of the specimens. - - Results: - - Double staining revealed numerous CD34+ blood vessels but only a few LYVE-1+ lymphatic vessels in BPH and PCa sections. Mean LVD ± SD was distinctly lower (0.55 ± 0.93) in PCa tissue than in tumor periphery (2.45 ± 1.93) and nontumorous (3.16 ± 2.23) tissue (p <0.0001). Maximum LVD was observed in BPH (7.17 ± 3.61), which differed markedly from nontumorous areas of PCa specimens (p <0.001). In contrast to LVD, significantly more blood vessels were found in PCa (116.00 ± 39.25) than in BPH (60.30 ± 19.34) tissue (p <0.001). - - Conclusions: - - LYVE-1 is a specific lymphatic endothelial marker in benign and malignant prostate tissues. It is a useful new marker for the investigation of lymphatics. To our knowledge we report the immunohistochemical visualization and quantification of lymphatic vessels in prostatic tissue for the first time. In contrast to the stimulated angiogenesis of blood vessels in PCa, the destruction of lymphatic vessels occurs rather than lymphangiogenesis. 
650 4 |a endothelium 
650 4 |a lymphangiogenesis 
650 4 |a prostate 
650 4 |a prostatic hyperplasia 
650 4 |a prostatic neoplasms 
700 1 |a Michel, Maurice Stephan  |d 1970-  |e VerfasserIn  |0 (DE-588)121842568  |0 (DE-627)705674134  |0 (DE-576)29291363X  |4 aut 
700 1 |a Rensch, Florian  |d 1978-  |e VerfasserIn  |0 (DE-588)130657239  |0 (DE-627)505292181  |0 (DE-576)250009889  |4 aut 
700 1 |a Jackson, David G.  |e VerfasserIn  |4 aut 
700 1 |a Alken, Peter  |d 1942-  |e VerfasserIn  |0 (DE-588)1036718352  |0 (DE-627)751026972  |0 (DE-576)385351941  |4 aut 
700 1 |a Grobholz, Rainer  |e VerfasserIn  |0 (DE-588)1068350679  |0 (DE-627)820163538  |0 (DE-576)427721032  |4 aut 
773 0 8 |i Enthalten in  |t The journal of urology  |d New York, NY [u.a.] : Elsevier, 1917  |g 172(2004), 1, Seite 103-107  |h Online-Ressource  |w (DE-627)313118213  |w (DE-600)2007912-6  |w (DE-576)095660194  |x 1527-3792  |7 nnas  |a Lymph and blood vessel architecture in benign and malignant prostatic tissue lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (lyve-1) 
773 1 8 |g volume:172  |g year:2004  |g number:1  |g pages:103-107  |g extent:5  |a Lymph and blood vessel architecture in benign and malignant prostatic tissue lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (lyve-1) 
856 4 0 |u https://doi.org/10.1097/01.ju.0000128860.00639.9c  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.auajournals.org/doi/10.1097/01.ju.0000128860.00639.9c  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220307 
993 |a Article 
994 |a 2004 
998 |g 1068350679  |a Grobholz, Rainer  |m 1068350679:Grobholz, Rainer  |d 60000  |e 60000PG1068350679  |k 0/60000/  |p 6  |y j 
998 |g 1036718352  |a Alken, Peter  |m 1036718352:Alken, Peter  |d 60000  |d 60000  |d 63100  |e 60000PA1036718352  |e 60000PA1036718352  |e 63100PA1036718352  |k 0/60000/  |k 0/60000/  |k 1/60000/63100/  |p 5 
998 |g 130657239  |a Rensch, Florian  |m 130657239:Rensch, Florian  |d 60000  |e 60000PR130657239  |k 0/60000/  |p 3 
998 |g 121842568  |a Michel, Maurice Stephan  |m 121842568:Michel, Maurice Stephan  |d 60000  |d 60000  |d 63100  |e 60000PM121842568  |e 60000PM121842568  |e 63100PM121842568  |k 0/60000/  |k 0/60000/  |k 1/60000/63100/  |p 2 
998 |g 124059856  |a Trojan, Lutz  |m 124059856:Trojan, Lutz  |d 60000  |e 60000PT124059856  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1794923179  |e 4080902883 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"part":{"pages":"103-107","volume":"172","extent":"5","issue":"1","year":"2004","text":"172(2004), 1, Seite 103-107"},"disp":"Lymph and blood vessel architecture in benign and malignant prostatic tissue lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (lyve-1)The journal of urology","corporate":[{"role":"isb","display":"American Urological Association"}],"pubHistory":["1.1917 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"313118213","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"journal of urology","subtitle":"official journal of the American Urological Society","title":"The journal of urology"}],"note":["Gesehen am 25.03.2022"],"id":{"issn":["1527-3792"],"eki":["313118213"],"zdb":["2007912-6"]},"origin":[{"publisher":"Elsevier ; Lippincott Williams & Wilkins","dateIssuedDisp":"1917-","dateIssuedKey":"1917","publisherPlace":"New York, NY [u.a.] ; Hagerstown, Md."}]}],"person":[{"role":"aut","display":"Trojan, Lutz","family":"Trojan","given":"Lutz"},{"family":"Michel","display":"Michel, Maurice Stephan","role":"aut","given":"Maurice Stephan"},{"given":"Florian","role":"aut","display":"Rensch, Florian","family":"Rensch"},{"given":"David G.","role":"aut","family":"Jackson","display":"Jackson, David G."},{"given":"Peter","family":"Alken","display":"Alken, Peter","role":"aut"},{"role":"aut","family":"Grobholz","display":"Grobholz, Rainer","given":"Rainer"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"1 Jul 2004"}],"id":{"eki":["1794923179"],"doi":["10.1097/01.ju.0000128860.00639.9c"]},"recId":"1794923179","note":["Gesehen am 07.03.2022"],"name":{"displayForm":["Lutz Trojan, Maurice Stephan Michel, Florian Rensch, David G. Jackson, Peter Alken, Rainer Grobholz"]},"language":["eng"],"physDesc":[{"extent":"5 S."}],"title":[{"subtitle":"lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (lyve-1)","title":"Lymph and blood vessel architecture in benign and malignant prostatic tissue","title_sort":"Lymph and blood vessel architecture in benign and malignant prostatic tissue"}]} 
SRT |a TROJANLUTZLYMPHANDBL1200